FDA to Hold Workshop on Mandatory Prescriber Education for Opioids

Sep 22, 2021
The U.S. Food and Drug Administration (FDA) announced on September 8 that it would be conducting a two-day public workshop, "Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis," to allow stakeholders to provide input on aspects of the current opioid crisis that could be mitigated measurably by requiring mandatory prescriber education as part of a REMS.